The cardiovascular catheters market size has grown strongly in recent years. It will grow from $21.87 billion in 2025 to $23.83 billion in 2026 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to reliance on conventional catheter technologies, increasing prevalence of cardiovascular diseases, growing hospital and clinic infrastructure, limited access to advanced therapeutic procedures, awareness of minimally invasive cardiovascular treatments.
The cardiovascular catheters market size is expected to see strong growth in the next few years. It will grow to $33.24 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to development of advanced therapeutic and diagnostic catheters, rising demand for outpatient and ambulatory surgical interventions, integration with imaging and digital monitoring systems, increasing cardiovascular procedure volumes, adoption of biocompatible and smart catheter materials. Major trends in the forecast period include rising adoption of minimally invasive procedures, growth in coronary artery disease interventions, increasing use of electrophysiology and ablation catheters, expansion of stent delivery and angioplasty balloon applications, focus on catheter material innovation and biocompatibility.
The increasing prevalence of vascular heart diseases is anticipated to support the expansion of the cardiovascular catheter market going forward. Vascular heart diseases include conditions affecting blood vessels supplying the heart or located within the heart itself. Factors such as aging populations, lifestyle-related changes, and higher rates of diabetes and hypertension contribute to the growing prevalence of these conditions. Cardiovascular catheters assist in minimally invasive procedures used to diagnose, treat, and manage vascular heart diseases, enabling faster recovery times and improved clinical outcomes. For example, in January 2024, according to the American Heart Association, a US-based nonprofit organization, cardiovascular disease-related deaths reached 931,578, with the age-adjusted death rate increasing to 233.3 per 100,000, reflecting a 4% year-over-year rise. Consequently, the increasing prevalence of vascular heart diseases is supporting growth across the cardiovascular catheter market.
Leading companies operating in the cardiovascular catheters market are developing innovative products incorporating advanced technologies, such as TRUEref technology, to enhance the accuracy and reliability of cardiac mapping procedures. TRUEref technology improves catheter performance by delivering accurate reference signals during cardiac mapping, enabling precise arrhythmia identification and more targeted treatment. For example, in July 2023, Biosense Webster Inc., a US-based company within Johnson & Johnson MedTech, launched the OPTRELL mapping catheter. This high-density diagnostic catheter, powered by the CARTO 3 System, features TRUEref technology and 48 small electrodes to deliver high-definition electrophysiological mapping, allowing clinicians to map complex arrhythmias with greater precision and develop more effective ablation strategies.
In April 2023, Abbott, a US-based medical device company, acquired Cardiovascular Systems Inc. for $890 million. This acquisition is intended to enhance Abbott’s vascular device portfolio by incorporating Cardiovascular Systems’ innovative atherectomy systems, thereby improving treatment options for peripheral and coronary artery diseases. The transaction enables Abbott to deliver more comprehensive care to patients with complex arterial conditions. Cardiovascular Systems Inc. is a US-based medical equipment manufacturer specializing in catheters and related devices for vascular disease treatment.
Major companies operating in the cardiovascular catheters market are Abbott Laboratories, Medtronic plc, Johnson & Johnson MedTech, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Nipro Corporation, Cook Group Incorporated, Biotronik SE & Co. KG, Merit Medical Systems Inc., LivaNova plc, Cordis Corporation, Asahi Intecc Co. Ltd., AngioDynamics Inc., Endologix Inc., Wellinq, Cardionovum GmbH, Avinger Inc., CathRx, Andocor NV.
Asia-Pacific was the largest region in the cardiovascular catheters market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cardiovascular catheters market by increasing costs for imported specialized materials such as advanced polymers, stent delivery components, and diagnostic catheters. Segments including therapeutic catheters like angioplasty balloons and stent delivery systems are particularly impacted, with Asia-Pacific regions such as China and India facing significant import duties. This has led to higher production costs and supply chain adjustments. On the positive side, tariffs have encouraged local manufacturing, innovation in catheter design, and investment in domestic production capabilities.
The cardiovascular catheters market research report is one of a series of new reports that provides cardiovascular catheters market statistics, including cardiovascular catheters industry global market size, regional shares, competitors with a cardiovascular catheters market share, detailed cardiovascular catheters market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular catheters industry. This cardiovascular catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular catheters are thin, flexible tubes inserted into blood vessels to perform diagnostic or therapeutic procedures within the heart and vascular system. They are vital for delivering treatments, monitoring blood flow, and assessing heart conditions, allowing minimally invasive access without the need for open surgery.
The main product categories in the cardiovascular catheters market include cardiovascular therapeutic catheters and cardiovascular diagnostic catheters. Cardiovascular therapeutic catheters are specialized devices used in minimally invasive interventions to treat cardiovascular conditions, including opening blocked arteries and correcting abnormal heart rhythms. The applications include coronary artery disease (CAD), cardiac arrhythmias, heart failure, and others, and the end users include hospitals, clinics, and ambulatory surgical centers.
The cardiovascular catheters market consists of sales of balloon catheters and electrophysiology catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cardiovascular catheters market size is expected to see strong growth in the next few years. It will grow to $33.24 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to development of advanced therapeutic and diagnostic catheters, rising demand for outpatient and ambulatory surgical interventions, integration with imaging and digital monitoring systems, increasing cardiovascular procedure volumes, adoption of biocompatible and smart catheter materials. Major trends in the forecast period include rising adoption of minimally invasive procedures, growth in coronary artery disease interventions, increasing use of electrophysiology and ablation catheters, expansion of stent delivery and angioplasty balloon applications, focus on catheter material innovation and biocompatibility.
The increasing prevalence of vascular heart diseases is anticipated to support the expansion of the cardiovascular catheter market going forward. Vascular heart diseases include conditions affecting blood vessels supplying the heart or located within the heart itself. Factors such as aging populations, lifestyle-related changes, and higher rates of diabetes and hypertension contribute to the growing prevalence of these conditions. Cardiovascular catheters assist in minimally invasive procedures used to diagnose, treat, and manage vascular heart diseases, enabling faster recovery times and improved clinical outcomes. For example, in January 2024, according to the American Heart Association, a US-based nonprofit organization, cardiovascular disease-related deaths reached 931,578, with the age-adjusted death rate increasing to 233.3 per 100,000, reflecting a 4% year-over-year rise. Consequently, the increasing prevalence of vascular heart diseases is supporting growth across the cardiovascular catheter market.
Leading companies operating in the cardiovascular catheters market are developing innovative products incorporating advanced technologies, such as TRUEref technology, to enhance the accuracy and reliability of cardiac mapping procedures. TRUEref technology improves catheter performance by delivering accurate reference signals during cardiac mapping, enabling precise arrhythmia identification and more targeted treatment. For example, in July 2023, Biosense Webster Inc., a US-based company within Johnson & Johnson MedTech, launched the OPTRELL mapping catheter. This high-density diagnostic catheter, powered by the CARTO 3 System, features TRUEref technology and 48 small electrodes to deliver high-definition electrophysiological mapping, allowing clinicians to map complex arrhythmias with greater precision and develop more effective ablation strategies.
In April 2023, Abbott, a US-based medical device company, acquired Cardiovascular Systems Inc. for $890 million. This acquisition is intended to enhance Abbott’s vascular device portfolio by incorporating Cardiovascular Systems’ innovative atherectomy systems, thereby improving treatment options for peripheral and coronary artery diseases. The transaction enables Abbott to deliver more comprehensive care to patients with complex arterial conditions. Cardiovascular Systems Inc. is a US-based medical equipment manufacturer specializing in catheters and related devices for vascular disease treatment.
Major companies operating in the cardiovascular catheters market are Abbott Laboratories, Medtronic plc, Johnson & Johnson MedTech, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Nipro Corporation, Cook Group Incorporated, Biotronik SE & Co. KG, Merit Medical Systems Inc., LivaNova plc, Cordis Corporation, Asahi Intecc Co. Ltd., AngioDynamics Inc., Endologix Inc., Wellinq, Cardionovum GmbH, Avinger Inc., CathRx, Andocor NV.
Asia-Pacific was the largest region in the cardiovascular catheters market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cardiovascular catheters market by increasing costs for imported specialized materials such as advanced polymers, stent delivery components, and diagnostic catheters. Segments including therapeutic catheters like angioplasty balloons and stent delivery systems are particularly impacted, with Asia-Pacific regions such as China and India facing significant import duties. This has led to higher production costs and supply chain adjustments. On the positive side, tariffs have encouraged local manufacturing, innovation in catheter design, and investment in domestic production capabilities.
The cardiovascular catheters market research report is one of a series of new reports that provides cardiovascular catheters market statistics, including cardiovascular catheters industry global market size, regional shares, competitors with a cardiovascular catheters market share, detailed cardiovascular catheters market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular catheters industry. This cardiovascular catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular catheters are thin, flexible tubes inserted into blood vessels to perform diagnostic or therapeutic procedures within the heart and vascular system. They are vital for delivering treatments, monitoring blood flow, and assessing heart conditions, allowing minimally invasive access without the need for open surgery.
The main product categories in the cardiovascular catheters market include cardiovascular therapeutic catheters and cardiovascular diagnostic catheters. Cardiovascular therapeutic catheters are specialized devices used in minimally invasive interventions to treat cardiovascular conditions, including opening blocked arteries and correcting abnormal heart rhythms. The applications include coronary artery disease (CAD), cardiac arrhythmias, heart failure, and others, and the end users include hospitals, clinics, and ambulatory surgical centers.
The cardiovascular catheters market consists of sales of balloon catheters and electrophysiology catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cardiovascular Catheters Market Characteristics
3. Cardiovascular Catheters Market Supply Chain Analysis
4. Global Cardiovascular Catheters Market Trends and Strategies
5. Cardiovascular Catheters Market Analysis of End Use Industries
7. Global Cardiovascular Catheters Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cardiovascular Catheters Total Addressable Market (TAM) Analysis for the Market
9. Cardiovascular Catheters Market Segmentation
10. Cardiovascular Catheters Market Regional and Country Analysis
11. Asia-Pacific Cardiovascular Catheters Market
12. China Cardiovascular Catheters Market
13. India Cardiovascular Catheters Market
14. Japan Cardiovascular Catheters Market
15. Australia Cardiovascular Catheters Market
16. Indonesia Cardiovascular Catheters Market
17. South Korea Cardiovascular Catheters Market
18. Taiwan Cardiovascular Catheters Market
19. South East Asia Cardiovascular Catheters Market
20. Western Europe Cardiovascular Catheters Market
21. UK Cardiovascular Catheters Market
22. Germany Cardiovascular Catheters Market
23. France Cardiovascular Catheters Market
24. Italy Cardiovascular Catheters Market
25. Spain Cardiovascular Catheters Market
26. Eastern Europe Cardiovascular Catheters Market
27. Russia Cardiovascular Catheters Market
28. North America Cardiovascular Catheters Market
29. USA Cardiovascular Catheters Market
30. Canada Cardiovascular Catheters Market
31. South America Cardiovascular Catheters Market
32. Brazil Cardiovascular Catheters Market
33. Middle East Cardiovascular Catheters Market
34. Africa Cardiovascular Catheters Market
36. Cardiovascular Catheters Market Competitive Landscape and Company Profiles
37. Cardiovascular Catheters Market Other Major and Innovative Companies
40. Cardiovascular Catheters Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Cardiovascular Catheters Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cardiovascular catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiovascular catheters? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular catheters market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Cardiovascular Therapeutic Catheters; Cardiovascular Diagnostic Catheters2) By Application: Coronary Artery Diseases (CAD); Cardiac Arrhythmia; Heart Failure; Other Applications
3) By End User: Hospitals; Clinics; Ambulatory Surgical Centers
Subsegments:
1) By Cardiovascular Therapeutic Catheters: Angioplasty Balloons; Stent Delivery Catheters; Catheters for Ablation Therapy; Intracardiac Catheters; Thrombectomy Catheters2) By Cardiovascular Diagnostic Catheters: Coronary Angiography Catheters; Pressure Monitoring Catheters; Electrophysiology Catheters; Intravenous Catheters for Diagnostic Imaging
Companies Mentioned: Abbott Laboratories; Medtronic plc; Johnson & Johnson MedTech; Koninklijke Philips N.V.; Stryker Corporation; Boston Scientific Corporation; B. Braun Melsungen AG; Terumo Corporation; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; ZOLL Medical Corporation; Nipro Corporation; Cook Group Incorporated; Biotronik SE & Co. KG; Merit Medical Systems Inc.; LivaNova plc; Cordis Corporation; Asahi Intecc Co. Ltd.; AngioDynamics Inc.; Endologix Inc.; Wellinq; Cardionovum GmbH; Avinger Inc.; CathRx; Andocor NV
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cardiovascular Catheters market report include:- Abbott Laboratories
- Medtronic plc
- Johnson & Johnson MedTech
- Koninklijke Philips N.V.
- Stryker Corporation
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Terumo Corporation
- Edwards Lifesciences Corporation
- W. L. Gore & Associates Inc.
- ZOLL Medical Corporation
- Nipro Corporation
- Cook Group Incorporated
- Biotronik SE & Co. KG
- Merit Medical Systems Inc.
- LivaNova plc
- Cordis Corporation
- Asahi Intecc Co. Ltd.
- AngioDynamics Inc.
- Endologix Inc.
- Wellinq
- Cardionovum GmbH
- Avinger Inc.
- CathRx
- Andocor NV
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 23.83 Billion |
| Forecasted Market Value ( USD | $ 33.24 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
